3,270 followers
The cover for issue 8 of Oncotarget features Figure 8, "MLN4924 treatment induces DNA damage by stabilizing CDT1 and accumulates the cells in S phase which are enhanced by MLN4924/cisplatin co-treatment," by Misra, et al. https://t.co/K8y4XHlxcC